News and Events

Tarcine Research Product Be Patented in Hong Kong

Tarcine BioMed has got the patent from Intellectual Property Department of HKSAR on the manufacturing process of Lp-PLA2 Chemiluminescence Immuno Assay (CLIA) kit which is developed by Tarcine BioMed.

The noise of this CLIA kit is reduced to the greatest limit, so the differentiation of the detection light and the baseline is strengthened resulting in enhanced specificity.

The application of this kit on prognosis of cardiovascular diseases is valuable and its market potential is enormous.

Tarcine BioMed will keep working hard on product development and more break-through on diagnostic kits can be expected.